Belgisch Centrum voor Farmacotherapeutische Informatie-Centre Belge d'Information Pharmacothérapeutique
0408.045.049 · rovalta.com · 28/09/2026
Belgisch Centrum voor Farmacotherapeutische Informatie-Centre Belge d'Information Pharmacothérapeutique
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBOBelgisch Centrum voor Farmacotherapeutische Informatie-Centre Belge d'Information Pharmacothérapeutique is a Non-profit organization incorporated in 1970. Its main activity is: Libraries, archives, museums and other cultural activities. Its registered office is in Saint-Josse-ten-Noode. It employs on average 23,7 ETP workers (FTE).
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0408.045.049
- Incorporation
- 30/12/1970
- Legal form
- Non-profit organization
- Registered office
- Avenue Galilée 5 box /3
1210 Saint-Josse-ten-Noode · BruxellesSee on map - Latest accounts
- 31/12/2025
- Average workforce
- 23,7 ETP
Joint committees (1)
- 337
Financials
Source · NBB, 20 filingsTrend over 18 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 2,6 M € | +3.5% | 2,5 M € | -5.7% | 2,6 M € | +8.7% | 2,4 M € | +11.1% | 2,2 M € |
| EBITDA | -97,6 k € | -112% | -46,1 k € | -121% | 224,5 k € | +28.7% | 174,4 k € | +16.6% | 149,6 k € |
| Operating result | -105,6 k € | -90.8% | -55,4 k € | -125% | 217,2 k € | +27.3% | 170,6 k € | +14.4% | 149,1 k € |
| Net result | -100,3 k € | -148% | -40,4 k € | -119% | 217,2 k € | +43.6% | 151,2 k € | +1.5% | 149,1 k € |
| Balance sheet | |||||||||
| Equity | 1,6 M € | -6.1% | 1,7 M € | -2.4% | 1,7 M € | +14.7% | 1,5 M € | +11.4% | 1,3 M € |
| Total assets | 2,3 M € | +0.5% | 2,3 M € | -4.0% | 2,4 M € | +2.0% | 2,4 M € | +7.0% | 2,2 M € |
| Cash | 1,1 M € | -35.0% | 1,7 M € | -6.7% | 1,8 M € | -2.5% | 1,8 M € | +20.7% | 1,5 M € |
| Debts | 782,8 k € | +16.8% | 670,3 k € | -7.8% | 727,3 k € | -7.1% | 783,2 k € | +21.8% | 643,2 k € |
| Other | |||||||||
| Workforce | 23,7 ETP | +4.9% | 22,6 ETP | +2.3% | 22,1 ETP | – | – | ||
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/202513 active · 26 ended
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Alain Dupont | Penningmeester22/04/2025 → 22/04/2027Director01/01/2006 → 13/06/2025endedMandateended | ||
André Herchuelz | Director01/01/2007 → 22/04/2027Chairman of the board of directors01/01/2007 → 31/12/2022endedMandateended | ||
Chris Ulens | Director11/06/2019 → 22/04/2027Mandateended | ||
Hendrik De Rocker | Director13/06/2023 → 22/04/2027Mandateended | ||
Jean-Marie Maloteaux | Vice-chairman of the board of directors22/04/2025 → 22/04/2027Director13/06/2023 → 13/06/2025endedMandateended | ||
Mathias Devreese | Director22/04/2025 → 22/04/2027 | ||
Pascal Gustin | Director01/01/2006 → 22/04/2027Mandateended | ||
Philippe Jorens | Director01/01/2009 → 22/04/2027 | ||
Stefan Degallaix | Director13/06/2023 → 22/04/2027 | ||
Stefan Teughels | Director13/06/2023 → 22/04/2027Mandateended | ||
Stéphanie Brillon | Director22/04/2025 → 22/04/2027 | ||
Thierry Christiaens | Chairman of the board of directors01/01/2014 → 22/04/2027Vice-chairman of the board of directors01/01/2012 → 31/12/2013endedDirector01/01/2009 → 13/06/2025endedMandateended | ||
Vincent Seutin | Director01/01/2011 → 22/04/2027Chairman of the board of directors01/01/2016 → 31/12/2020endedVice-chairman of the board of directors01/01/2014 → 31/12/2015endedMandateended |
Ended mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Guido De Meyer | Director13/06/2023 → 13/06/2025 | ||
Lionel LAURIER | Director01/01/2021 → 31/12/2022 | ||
Thomas DE RIJDT | Director01/01/2021 → 31/12/2022 | ||
Isabelle ROLAND | Director11/06/2019 → 31/12/2021 |
Other companies at this address
Avenue Galilée 5 1210 Saint-Josse-ten-Noode| Company | CBE no. |
|---|---|
| 0884.579.424 | |
| 0841.650.687 | |
| 0407.664.373 | |
| 0746.392.234 | |
Cellule technique INAMI● Active | 0500.591.858 |
Club Delta● Active | 0412.395.005 |
| 0403.261.761 | |
| 0642.738.925 | |
Fondation Registre du Cancer● Active | 0874.845.671 |
| 0206.653.946 | |
NUBEL - NUTRIENTEN BELGIE● Active | 0442.973.561 |
| 0800.309.782 | |
| 0367.303.762 | |
| 0409.196.973 | |
Tonibell● Liquidation | 0402.832.090 |
| 0419.262.506 | |
Vedeha● Active | 0402.670.655 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Micro model | Micro model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 20/05/2026 | 16/06/2025 | 29/04/2024 | 27/06/2023 | 11/07/2022 | 05/08/2021 |
| General meeting | 21/04/2026 | 22/04/2025 | 16/04/2024 | 13/06/2023 | 16/06/2022 | 01/05/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 20 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 21/04/2026 | 20/05/2026 | Dutch | |
| Abridged model | 31/12/2024 | 22/04/2025 | 16/06/2025 | Dutch | |
| Abridged model | 31/12/2023 | 16/04/2024 | 29/04/2024 | Dutch | |
| Micro model | 31/12/2022 | 13/06/2023 | 27/06/2023 | French | |
| Micro model | 31/12/2021 | 16/06/2022 | 11/07/2022 | Dutch | |
| Abridged model | 31/12/2020 | 01/05/2021 | 05/08/2021 | French | |
| Abridged model | 31/12/2019 | 02/06/2020 | 25/09/2020 | French | |
| Abridged model | 31/12/2018 | 22/10/2019 | 04/12/2019 | French | |
| Abridged model | 31/12/2017 | 12/06/2018 | 07/11/2018 | French | |
| Abridged model | 31/12/2016 | 06/06/2017 | 26/11/2017 | French | |
| Abridged model | 31/12/2015 | 07/06/2016 | 28/11/2016 | French | |
| Abridged model | 31/12/2014 | 16/05/2015 | 30/12/2015 | French | |
| Abridged model | 31/12/2013 | 17/06/2014 | 02/12/2014 | French | |
| Abridged model | 31/12/2012 | 16/05/2013 | 31/07/2013 | French | |
| Abridged model | 31/12/2011 | 14/06/2012 | 30/07/2012 | French | |
| Abridged model | 31/12/2010 | 30/06/2011 | 14/11/2011 | French | |
| Abridged model | 31/12/2009 | 10/06/2010 | 29/11/2010 | French | |
| Abridged model | 31/12/2008 | 23/06/2009 | 28/02/2010 | French | |
| Abridged model | 31/12/2007 | 19/06/2008 | 07/11/2008 | Dutch | |
| Abridged model | 31/12/2006 | 28/06/2007 | 24/09/2007 | French |
Valuation
Indicative valuation
As an indication, this company is worth
between 1 M€ and 2,5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/202513 active · 26 ended
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Alain Dupont | Penningmeester22/04/2025 → 22/04/2027Director01/01/2006 → 13/06/2025endedMandateended | ||
André Herchuelz | Director01/01/2007 → 22/04/2027Chairman of the board of directors01/01/2007 → 31/12/2022endedMandateended | ||
Chris Ulens | Director11/06/2019 → 22/04/2027Mandateended | ||
Hendrik De Rocker | Director13/06/2023 → 22/04/2027Mandateended | ||
Jean-Marie Maloteaux | Vice-chairman of the board of directors22/04/2025 → 22/04/2027Director13/06/2023 → 13/06/2025endedMandateended | ||
Mathias Devreese | Director22/04/2025 → 22/04/2027 | ||
Pascal Gustin | Director01/01/2006 → 22/04/2027Mandateended | ||
Philippe Jorens | Director01/01/2009 → 22/04/2027 | ||
Stefan Degallaix | Director13/06/2023 → 22/04/2027 | ||
Stefan Teughels | Director13/06/2023 → 22/04/2027Mandateended | ||
Stéphanie Brillon | Director22/04/2025 → 22/04/2027 | ||
Thierry Christiaens | Chairman of the board of directors01/01/2014 → 22/04/2027Vice-chairman of the board of directors01/01/2012 → 31/12/2013endedDirector01/01/2009 → 13/06/2025endedMandateended | ||
Vincent Seutin | Director01/01/2011 → 22/04/2027Chairman of the board of directors01/01/2016 → 31/12/2020endedVice-chairman of the board of directors01/01/2014 → 31/12/2015endedMandateended |
Ended mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Guido De Meyer | Director13/06/2023 → 13/06/2025 | ||
Lionel LAURIER | Director01/01/2021 → 31/12/2022 | ||
Thomas DE RIJDT | Director01/01/2021 → 31/12/2022 | ||
Isabelle ROLAND | Director11/06/2019 → 31/12/2021 |
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Mandates26/05/2025DEMISSIONS, NOMINATIONS
- Mandates26/05/2025ONTSLAGEN - BENOEMINGEN
- Mandates31/01/2025DEMISSIONS, NOMINATIONS
- Mandates31/01/2025ONTSLAGEN - BENOEMINGEN
- Other16/02/2024DIVERS
- Mandates16/02/2024DEMISSIONS, NOMINATIONS
- Registered office16/02/2024ADRESSE AUTRE QUE SIEGE SOCIAL - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
- Registered office09/10/2023MAATSCHAPPELIJKE ZETEL - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
Source · CBE, NBB annual accountsRegistered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Avenue Galilée 5 bte /3, 1210 Saint-Josse-ten-NoodeCurrent | CBE | |
| GALILEELAAN 5/03, 1210 Saint-Josse-ten-Noode | accounts 2023 → 2025 | Accounts 2025 · 2026-00116366 |
| Corneel Heymanslaan 10, 9000 Gent | accounts 2021 → 2022 | Accounts 2022 · 2023-00174731 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| Belgisch Centrum voor Farmacotherapeutische Informatie-Centre Belge d'Information PharmacothérapeutiqueCurrent | CBE | |
| BCFI - CBIP | accounts 2023 → 2025 | Accounts 2025 · 2026-00116366 |
| Belgisch Centrum voor Farmacoterapeutische Informatie-Centre belge d'Information pharmacothérapeutique | accounts 2022 | Accounts 2022 · 2023-00174731 |
| Belgisch Centrum voor Farmacoterapeutische Informatie-Centre belge d'Informatique pharmacothérapeutique | accounts 2021 | Accounts 2021 · 2022-20168564 |
Events
- 2025Annual accounts 2025-100,3 k €↓
- 2024Annual accounts 2024-40,4 k €↓
- 2023Annual accounts 2023217,2 k €↑
- 2023Name changeBCFI - CBIP
- 2022Annual accounts 2022151,2 k €↑
- 2022Name changeBelgisch Centrum voor Farmacoterapeutische Informatie-Centre belge d'Information pharmacothérapeutique
- 2021Annual accounts 2021149,1 k €↑
- 2020Annual accounts 2020-57 k €↓
- 2019Annual accounts 2019-9 k €↓
- 2018Annual accounts 2018380,5 k €↑
- 2017Annual accounts 2017206,9 k €↑
- 2016Annual accounts 201626,1 k €↑
- 2015Annual accounts 201518,2 k €↓
- 2014Annual accounts 201447,3 k €↓
- 2013Annual accounts 201347,4 k €↑
- 2012Annual accounts 201245 k €↓
- 2011Annual accounts 2011223,7 k €↑
- 2010Annual accounts 2010-2,4 k €↓
- 2009Annual accounts 2009255,5 k €↑
- 2008Annual accounts 20089,8 k €
- 30/12/1970IncorporationNon-profit organization